Patent · US Active

Anti-CD39 antibodies

US11345757B2 · kind B2 · utility

0Cited by

15References

7Claims

0Family size

Assignee

Trishula Therapeutics, Inc. · US

Inventors

Vanessa Soros · South San Francisco, US
Maria Kovalenko · Portola Valley, US
John Corbin · Oakland, US
Courtney Beers · Seattle, US
Paul Fredrick Widboom · Lebanon, US
Joseph Robert Warfield · South San Francisco, US

Key dates

Filing date	Jul 30, 2018
Grant date	May 31, 2022
Priority date	—
Expiry date	Jul 30, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.